Spyre Therapeutics, Inc. SEC filings SYRE
Spyre Therapeutics, Inc. has 823 filings in SEC EDGAR's recent list, going back to Mar 24, 2015. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 6, 2026 | — |
| 424B5 | Prospectus supplement | Oct 5, 2026 | — |
| S-3ASR | Automatic shelf registration | Jun 26, 2026 | — |
| 424B5 | Prospectus supplement | Apr 16, 2026 | — |
| 424B5 | Prospectus supplement | Apr 13, 2026 | — |
| POS AM | Filing | Feb 27, 2026 | — |
| S-3 | Shelf registration | Feb 19, 2026 | — |
| S-8 | Employee stock plan registration | Feb 19, 2026 | — |
| 424B5 | Prospectus supplement | Oct 14, 2025 | — |
| 424B5 | Prospectus supplement | Oct 14, 2025 | — |
| S-8 | Employee stock plan registration | Aug 5, 2025 | — |
| POS AM | Filing | Mar 7, 2025 | — |
| S-3 | Shelf registration | Feb 27, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 424B5 | Prospectus supplement | Nov 19, 2024 | — |
| 424B5 | Prospectus supplement | Nov 18, 2024 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| S-3 | Shelf registration | Sep 20, 2024 | — |
| S-3 | Shelf registration | Sep 6, 2024 | — |
| 424B3 | Prospectus | Aug 8, 2024 | — |
| 424B3 | Prospectus | May 15, 2024 | — |
| S-1 | Registration statement | Apr 19, 2024 | — |
| POS AM | Filing | Mar 27, 2024 | — |
| S-1/A | Amended registration statement | Mar 27, 2024 | — |
| 424B3 | Prospectus | Mar 18, 2024 | — |
| POS AM | Filing | Mar 14, 2024 | — |
| S-1/A | Amended registration statement | Mar 14, 2024 | — |
| POS AM | Filing | Mar 5, 2024 | — |
| S-1/A | Amended registration statement | Mar 1, 2024 | — |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| 424B3 | Prospectus | Feb 7, 2024 | — |
| S-1/A | Amended registration statement | Feb 5, 2024 | — |
| S-8 | Employee stock plan registration | Dec 22, 2023 | — |
| S-1 | Registration statement | Dec 22, 2023 | — |
| 424B3 | Prospectus | Dec 8, 2023 | — |
| 424B3 | Prospectus | Nov 30, 2023 | — |
| S-1/A | Amended registration statement | Nov 15, 2023 | — |
| S-1/A | Amended registration statement | Oct 10, 2023 | — |
| S-3 | Shelf registration | Aug 7, 2023 | — |
| S-8 | Employee stock plan registration | Mar 2, 2023 | — |
| 424B5 | Prospectus supplement | Mar 2, 2023 | — |
| 424B5 | Prospectus supplement | May 20, 2022 | — |
| 424B5 | Prospectus supplement | May 6, 2022 | — |
| FWP | Free writing prospectus | May 5, 2022 | — |
| S-8 | Employee stock plan registration | Mar 8, 2022 | — |
| 424B5 | Prospectus supplement | Feb 9, 2022 | — |
| S-3 | Shelf registration | May 28, 2021 | — |
| S-8 | Employee stock plan registration | Mar 18, 2021 | — |
| S-3 | Shelf registration | Jul 6, 2020 | — |
| 424B5 | Prospectus supplement | Apr 28, 2020 | — |
| 424B5 | Prospectus supplement | Apr 27, 2020 | — |
| 424B5 | Prospectus supplement | Apr 16, 2020 | — |
| S-8 | Employee stock plan registration | Feb 24, 2020 | — |
| S-8 | Employee stock plan registration | Mar 7, 2019 | — |
| 424B5 | Prospectus supplement | Feb 13, 2019 | — |
| S-3/A | Filing | Feb 11, 2019 | — |
| 424B5 | Prospectus supplement | Feb 7, 2019 | — |
| 424B5 | Prospectus supplement | Feb 5, 2019 | — |
| S-3 | Shelf registration | Dec 21, 2018 | — |
| 424B5 | Prospectus supplement | Apr 19, 2018 | — |
| 424B5 | Prospectus supplement | Apr 17, 2018 | — |
| S-8 | Employee stock plan registration | Mar 13, 2018 | — |
| 424B5 | Prospectus supplement | Jun 6, 2017 | — |
| 424B5 | Prospectus supplement | Jun 5, 2017 | — |
| 424B5 | Prospectus supplement | May 31, 2017 | — |
| S-3/A | Filing | May 23, 2017 | — |
| S-3 | Shelf registration | May 1, 2017 | — |
| S-8 | Employee stock plan registration | Mar 23, 2017 | — |
| 424B4 | Prospectus | Apr 7, 2016 | — |
| POS AM | Filing | Apr 7, 2016 | — |
| S-8 | Employee stock plan registration | Apr 7, 2016 | — |
| S-1/A | Amended registration statement | Apr 6, 2016 | — |
| S-1/A | Amended registration statement | Mar 28, 2016 | — |
| S-1/A | Amended registration statement | Mar 14, 2016 | — |
| S-1/A | Amended registration statement | Nov 5, 2015 | — |
| S-1/A | Amended registration statement | Sep 14, 2015 | — |
| S-1 | Registration statement | Jun 16, 2015 | — |
Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SYRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1636282
- Former names
- Aeglea BioTherapeutics, Inc. (until Nov 24, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.